{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:12:41Z","timestamp":1759536761277,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1053\/j.ajkd.2018.11.013","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T03:04:19Z","timestamp":1550199859000},"page":"576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Critical Considerations in Genetic Counseling of Patients With the NPHS2 R229Q Variant"],"prefix":"10.1053","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-6212","authenticated-orcid":false,"given":"Kalman","family":"Tory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2018.06.034","article-title":"Nephrotic syndrome with mutations in NPHS2: the\u00a0role\u00a0of\u00a0R229Q and implications for genetic counseling","volume":"73","author":"Rood","year":"2019","journal-title":"Am\u00a0J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2898","article-title":"Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome","volume":"46","author":"Tory","year":"2014","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.ajkd.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bbadis.2018.04.008","article-title":"C-Terminal oligomerization of podocin mediates interallelic interactions","volume":"1864","author":"Straner","year":"2018","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1053\/j.ajkd.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ki.2008.650","article-title":"Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant","volume":"75","author":"Machuca","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2215\/CJN.02690806","article-title":"Recessive NPHS2 (podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis","volume":"2","author":"He","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A\u00a0single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/humu.23660","article-title":"The mutation-dependent pathogenicity of NPHS2 p.R229Q: a guide for clinical assessment","volume":"39","author":"Miko","year":"2018","journal-title":"Hum Mutat"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619300320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619300320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:17:08Z","timestamp":1759461428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619300320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0272638619300320"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.11.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical Considerations in Genetic Counseling of Patients With the NPHS2 R229Q Variant","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}